These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Glioblastoma in the elderly: an age-old problem. de Robles P; Cairncross G Ann Neurol; 2008 Dec; 64(6):597-9. PubMed ID: 19107994 [No Abstract] [Full Text] [Related]
24. Survival outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy. Blumenthal DT; Schulman SF Expert Rev Neurother; 2005 Sep; 5(5):683-90. PubMed ID: 16162092 [TBL] [Abstract][Full Text] [Related]
32. [A trial of rabies vaccine treatment of patients with glioblastoma multiforme]. Filipov FV Zh Vopr Neirokhir Im N N Burdenko; 1988; (3):38-40. PubMed ID: 2842989 [TBL] [Abstract][Full Text] [Related]
33. Integrative tumor board: glioblastoma multiforme. Dixit S; Pueschel JK; Wallace JM; Bolletino RC; Block KI Integr Cancer Ther; 2004 Jun; 3(2):149-72. PubMed ID: 15165500 [No Abstract] [Full Text] [Related]
34. Does the existing standard of care increase glioblastoma energy metabolism? Seyfried TN; Shelton LM; Mukherjee P Lancet Oncol; 2010 Sep; 11(9):811-3. PubMed ID: 20634134 [No Abstract] [Full Text] [Related]
36. Current concepts and management of glioblastoma. Preusser M; de Ribaupierre S; Wöhrer A; Erridge SC; Hegi M; Weller M; Stupp R Ann Neurol; 2011 Jul; 70(1):9-21. PubMed ID: 21786296 [TBL] [Abstract][Full Text] [Related]
37. A silver lining on the horizon for glioblastoma. Knisely JP; Baehring JM Lancet Oncol; 2009 May; 10(5):434-5. PubMed ID: 19410186 [No Abstract] [Full Text] [Related]
38. [Immunotherapy for malignant glioblastoma]. Nose T; Nakagawa K No Shinkei Geka; 1995 Mar; 23(3):195-206. PubMed ID: 7700486 [No Abstract] [Full Text] [Related]
39. An example of how patient selection can influence survival in glioblastoma multiforme. Gilbert HA; Cassidy F; Wagner J; Eder D; Kagan AR; Cove JK Cancer Clin Trials; 1978; 1(2):103-5. PubMed ID: 229979 [TBL] [Abstract][Full Text] [Related]